Dr. Edward S. Lee, M.D.
Plastic Surgery (Plastic and Reconstructive Surgery Physician)
140 Bergen St Ste E1620
Newark, NJ 07103
Who else practices at this address →
Essex County includes primary care (34% of residents) and mental health (11% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Georgetown University School of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 62
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Georgetown University School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Plastic and Reconstructive Surgery Physician primary
NJ license 25MA08409800 -
Plastic Surgery Physician
NY license 249420-1
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Jersey City Medical Center Jersey City, NJ
- The University Hospital Newark, NJ
Medical groups
- University Physician Associates of New Jersey Inc (378 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 62
- Services billed
- 292
- Patients’ average age
- 66
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Oxycodone Hcl Other prescribers in Newark, NJ | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 55 payments worth $28,567 in total to this clinician.
| Musculoskeletal Transplant Foundation Inc. | $25,551 |
|---|---|
| Tela Bio, Inc. | $718 |
| AbbVie Inc. | $441 |
| Polynovo North America LLC | $366 |
| Integra Lifesciences Corporation | $311 |
| Axogen | $279 |
| Mentor Worldwide LLC | $227 |
| Avita Medical Americas, LLC | $211 |
| Consulting Fee | $21,875 |
|---|---|
| Food and Beverage | $5,655 |
| Travel and Lodging | $1,037 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. Jul 2, 2025 | Consulting Fee | $12,950 |
| Musculoskeletal Transplant Foundation Inc. Jul 2, 2025 | Consulting Fee | $8,925 |
| Musculoskeletal Transplant Foundation Inc. Jul 2, 2025 | Travel and Lodging travel to Edison, NJ | $650 |
| Musculoskeletal Transplant Foundation Inc. Jul 17, 2025 | Travel and Lodging travel to Edison, NJ · in-kind | $387 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $3,174 in research payments for these studies, mostly to the institutions running them.
- Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
AbbVie Inc. · Recruiting · NCT06575192 - M24-708 - Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.